Vascular calcification: an update on mechanisms and challenges in treatment

Area of Science:

• Cardiovascular Biology
• Vascular Biology
• Mineral Metabolism

Background:

• Vascular calcification significantly increases cardiovascular disease mortality, especially in patients with diabetes and chronic kidney disease (CKD).
• It manifests as intimal calcification (atherosclerosis) or medial calcification (vascular stiffness), and valve calcification (stenosis).
• Once considered a passive aging process, vascular calcification is now understood as an active, regulated process akin to bone metabolism.

Purpose of the Study:

• To review the current understanding of vascular calcification mechanisms.
• To highlight the emerging roles of the RANK/RANKL/osteoprotegerin (OPG) system, osteoclasts, and microRNAs.
• To discuss potential therapeutic strategies for vascular calcification.

Main Methods:

• Literature review of recent studies on vascular calcification.
• Analysis of molecular mechanisms and cellular processes involved.
• Examination of therapeutic approaches derived from bone and CKD treatments.

Main Results:

• Vascular calcification is an active, regulated process involving pathways similar to bone metabolism.
• The RANK/RANKL/OPG signaling pathway, osteoclasts, and microRNAs are key regulators.
• Existing treatments for osteoporosis and CKD show promise for managing vascular calcification.

Conclusions:

• Vascular calcification is a complex, actively regulated process with significant clinical implications.
• Targeting pathways like RANK/RANKL/OPG and utilizing microRNAs offers novel therapeutic avenues.
• Further research into these mechanisms could lead to effective treatments to prevent or reverse vascular calcification.